Healthcare -
Biotechnology - NASDAQ - US
$ 5.435
-1.54 %
$ 372 M
Market Cap
-0.95
P/E
PHAT - OPERATING EXPENSES
Operating Expenses PHAT - Phathom Pharmaceuticals, Inc.
168 M
LAST VALUE
11.46%
2 YEAR CAGR
167.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR